References
- Anand, S.B., Murugan, V., Prabhu, P.R., Anandharaman, V., Reddy, M.V., Kaliraj, P. (2008): Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. Acta Trop., (107)2: 106 – 112. DOI: 10.1016/j.actatropica.2008.04.018
- Arnon, R., Tarrab-Hazdai, R., Steward M. (2000): A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization. Immunology, (101): 555 – 562. DOI: 10.1046/j.1365-2567.2000.00139.x
- Audibert, F., Chédid, L., Lefrancier, P., Choay. J. (1976): Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell. Immunol., 21(2) 243 – 249
- Blaxter, M., Aslett, M., Guiliano, D., Daub, J. (1999): Parasitic helminth genomics. Filarial Genome Project. Parasitology, 118: S39 – S51
- Brewer, J.M., Conacher, M., Mohrs, M., Brombacher, F., Alexander, J. (1999): Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signalling. J. Immunol., 163: 6448 – 6454
- Dakshinamoorthy, G., Samykutty, A.K., Munirathinam, G., Reddy, M.V., Kalyanasundaram, R. (2013): Multivalent fusion protein vaccine for lymphatic filariasis. Vaccine, 31(12): 1616 – 1622. DOI: 10.1016/j.vaccine.2012.09.055
- Ellouz, F., Adam, A., Ciorbaru, R., Lederer, E. (1974): Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun., 59(4): 1317 – 1325. DOI: 10.1016/0006-291X(74)90458-6
- Freedman, D.O., Nutman, T.B., Ottesen, E.A. (1989): Protective immunity in Bancroftian filariasis- Selective recognition of a 43- kDa larval stage antigen by infection free individuals in an endemic area. J.Clin. Invest., (83): 14 – 22
- Gobec, S., Sollner-Dolenc, M., Urleb, U., Wraber, B., Simcic, S., Filipic, M. (2004): Modulation of cytokine production by some phthalimido-desmuramyl dipeptides and their cytotoxicity. Farmaco, 59(5): 345 – 352. DOI: 10.1016/j.farmac.2004.01.003
- Gregory, W.F., Atmadja, A.K., Allen, J.E., Maizels, R.M. (2000): The abundant larval transcript 1/2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect. Immun., (68): 4174 – 4179. DOI: 10.1128/IAI.68.7.4174-4179.2000
- Hashimoto, S., Matsumoto, K., Gon, Y., Furuichi, S., Maruoka, S., Takeshita, I., Hirota, K., Yodoi, J., Horie, T. (1999): Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun., 258: 443 – 447. DOI: 10.1006/bbrc.1999.0658
- Hoerauf, A. (2008): Filariasis: new drugs and new opportunities for lymphatic filariasis and Onchocerciasis. Curr. Opin. Infect. Dis., 21: 673 – 681. DOI: 10.1097/QCO.0b013e328315cde7
- Kunchithapautham, K., Padmavathi, B., Narayanan, R.B., Kaliraj, P., Scott, A.L. (2003): Thioredoxin from Brugia malayi: Defining a 16-Kilodalton Class of Thioredoxins from Nematodes. Infect. Immun., 71: 4119 – 4126. DOI: 10.1128/IAI.71.7.4119-4126.2003
- Lawrence, R.A., Devaney, E. (2001): Lymphatic filariasis: parallels between the immunology of infection in humans and mice. Parasite Immunol., 23: 353 – 361. DOI: 10.1046/j.1365-3024.2001.00396.x
- Löwy, I., Leclerc, C., Chedid, L. (1980): Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives. Immunology, 39 (3): 441 – 450
- Madhumathi, J., Anugraha, G., Prince, P.R., Pradiba, D., Kaliraj, P. (2011): Proliferative responses of Brugia malayi TPX-1 and its epitopic peptide29–43 in an endemic population of human lymphatic filariasis. Microbes Infect., 13: 602 – 607. DOI: 10.1016/j.micinf.2011.01.008
- Madhumathi, J., Prince, P.R., Anugraha, G., Kiran, P., Rao, D.N., Reddy, M.V., Kaliraj, P. (2010): Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis. Vaccine, 28: 5038 – 5048. DOI: 10.1016/j.vaccine.2010.05.012
- Maizels, R.M., Blaxter, M.L., Scott, A.L. (2001): Immunological genomics of Brugia malayi: filarial genes implicated in immune evasion and protective immunity. Parasite Immunol., 23: 327 – 344. DOI: 10.1046/j.1365-3024.2001.00397.x
- McKee, A.S., Munks, M.W., MacLeod, M.K.L., Fleenor, C.J., Van Rooijen, N., Kappler, J.W., Marrack, P. (2009): Alum induces innate immune responses through macrophage and mast cell sensors, but these are not required for alum to act as an adjuvant for specific immunity. J Immunol., 183(7): 4403 – 4414. DOI: 10.4049/jimmunol.0900164
- Moschos, S.A., Bramwell, VW., Somavarapu, S., Alpar, H.O. (2005): Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine, 23(16): 1923 – 1930. DOI: 10.1016/j.vaccine.2004.10.016
- Nardin, E.H., Calvo-Calle, J.M., Oliveira, G.A., Nussenzweig, R.S., Schneider, M., Tiercy, J.M., Loutan, L., Hochstrasser, D., Rose, K. (2001): A Totally Synthetic Polyoxime Malaria Vaccine Containing Plasmodium falciparum B cell and Universal T Cell Epitopes Elicits Immune Responses in Volunteers of Diverse HLA types. J. Immunol., 166: 481 – 489. DOI: 10.4049/jimmunol.166.1.481
- Ottesen, E.A., Hooper, P.J., Bradley, M., Biswas, G. (2008): The Global Programme to Eliminate Lymphatic Filariasis: Health impact after 8 years. PLoS Negl. Trop. Dis., 2(10): e317. DOI: 10.1371/journal.pntd.0000317
- Parant, M. (1979): Biologic Properties of a New Synthetic Adjuvant, Muramyl Dipeptide (MDP). Springer Semin. Immunopathol., 2: 101 – 118. DOI: 10.1007/BF00201976
- Petrovsky, N., Aguilar, J.C. (2004): Vaccine adjuvants: current state and future trends. Immunol. Cell. Biol., 82(5): 488 – 496. DOI:10.1111/j.0818-9641.2004.01272.x
- Rajan, B., Ramalingam, T., Rajan, T.V. (2005): Critical Role for IgM in Host Protection in Experimental Filarial Infection. J. Immunol., 175: 1827 – 1833. DOI: 10.4049/jimmunol.175.3.1827
- Thirugnanam, S., Pandiaraja, P., Ramaswamy, K., Murugan, V., Gnanasekar, M., Nandakumar, K., Reddy, M.V., Kaliraj, P. (2007): Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Exp. Parasitol., 116: 483 – 491. DOI: 10.1016/j.exppara.2007.02.017
- Vanam, U., Pandey, V., Prabhu, P.R., Dakshinamurthy, G., Reddy, M.V., Kaliraj, P. (2009): Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. Am. J. Trop. Med. Hyg., 80(2): 319 – 324
- Veerapathran, A., Dakshinamoorthy, G., Gnanasekar, M., Reddy, M.V., Kalyanasundaram, R. (2009): Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. PLoS Negl. Trop. Dis., 3(6): 457. DOI:10.1371/journal.pntd.0000457
- Wack, A., Rappuoli, R. (2005): Vaccinology at the beginning of the 21st century. Curr. Opin. Immunol., 17(4): 411 – 418. DOI: 10.1016/j.coi.2005.05.005
- WHO (2011): Integrated vector management to control malaria and lymphatic filariasis – WHO Position Statement. Wkly. Epidemiol. Rec., 86(13): 121 – 127
- Wood, D.D., Staruch, M.J. (1980): Control of the mitogenicity of muramyl dipeptide. Int. J. Immunopharmacol., 3(1): 31 – 44. DOI: 10.1016/0192-0561(81)90043-6